Highlights of the year in JACC 2010

Journal of the American College of Cardiology

Volumn 57, Issue 4, 2011, Pages 480-514

  Demaria, Anthony N ^a   Bax, Jeroen J ^b   Ben Yehuda, Ori ^a   Feld, Gregory K ^a   Greenberg, Barry H ^a   Hall, Jennifer ^c   Hlatky, Mark ^d   Lew, Wilbur Y W ^e   Lima, Joo A C ^f   Maisel, Alan S ^e   Narayan, Sanjiv M ^e   Nissen, Steven ^g   Sahn, David J ^h   Tsimikas, Sotirios ^a  

^a UCSD MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MINNESOTA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; AMIODARONE; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CYTOCHROME P450 2C19; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; MIPOMERSEN; NITRIC OXIDE; PACLITAXEL; PRASUGREL; PROBUCOL; RANOLAZINE; RAPAMYCIN; ROSUVASTATIN; SILDENAFIL; TENECTEPLASE; TIROFIBAN; UNINDEXED DRUG; ZOTAROLIMUS;

ABLATION THERAPY; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALCOHOL CONSUMPTION; ALCOHOL SEPTAL ABLATION; ANEMIA; ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; BARE METAL STENT; BELOW KNEE AMPUTATION; BLEEDING; BLOOD CLOT LYSIS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVERSION; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CHROMOSOME 4Q; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGENITAL HEART DISEASE; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DEFIBRILLATOR; DIARRHEA; DOSE RESPONSE; DRUG COST; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY CARE; ENDOTHELIAL DYSFUNCTION; ERYTHEMA; FEMALE; FONTAN PROCEDURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; KIDNEY DISEASE; LEUKOCYTE COUNT; LIMB ISCHEMIA; LOADING DRUG DOSE; LONG QT SYNDROME; METABOLIC SYNDROME X; MITRAL VALVE REGURGITATION; MUSCLE RESECTION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHARMACOGENOMICS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEOLYTIC THROMBECTOMY; RISK ASSESSMENT; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS NODE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STENT; STENT THROMBOSIS; SYNCOPE; THERAPY DELAY; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOELASTOGRAPHY; VOMITING;

EID: 78751700078     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.12.007     Document Type: Review

References (265)

1. B.R. Brodie, B.J. Gersh, and T. Stuckey When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials J Am Coll Cardiol 56 2010 407 413
2. J.M. ten Berg, A.W.J. van't Hof, T. Dill On-TIME 2 Study Group Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome J Am Coll Cardiol 55 2010 2446 2455
3. T.A. Fischell, D.R. Fischell, and A. Avezum Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia J Am Coll Cardiol 56 2010 1089 1098
4. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
5. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis J Am Coll Cardiol 56 2010 11132
6. A. Romero-Corral, F.H. Sert-Kuniyoshi, and J. Sierra-Johnson Modest visceral fat gain causes endothelial dysfunction in healthy humans J Am Coll Cardiol 56 2010 662 666
7. B.J. Arsenault, J.S. Rana, and E.S.G. Stroes Beyond low-density lipoprotein cholesterol: respective contributions of nonhigh-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women J Am Coll Cardiol 55 2010 35 41
8. S. Costanzo, A. Di Castelnuovo, M.B. Donati, L. Iacoviello, and G. de Gaetano Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis J Am Coll Cardiol 55 2010 1339 1347
9. P.K. Shah Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 56 2010 98 105
10. M.S. Lauer Screening asymptomatic subjects for subclinical atherosclerosis: not so obvious J Am Coll Cardiol 56 2010 106 108
11. V. Nambi, L. Chambless, and A.R. Folsom Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study J Am Coll Cardiol 55 2010 1600 1607
12. J.H. Stein, and H.M. Johnson Carotid intima-media thickness, plaques, and cardiovascular disease risk: implications for preventive cardiology guidelines J Am Coll Cardiol 55 2010 1608 1610
13. S. Costanzo, A. Di Castelnuovo, M.B. Donate, L. Iacoviello, and G. de Gaetano Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis J Am Coll Cardiol 55 2010 1339 1347
14. Y. Matsuzawa, S. Sugiyama, and K. Sugamura Digital assessment of endothelial function and ischemic heart disease in women J Am Coll Cardiol 55 2010 1688 1696
15. M. Hamer, E. Stamatakis, M. Kivimaki, G.D. Lowe, and G.D. David Batty Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors? J Am Coll Cardiol 56 2010 18 23
16. H. Tomiyama, H. Hashimoto, and H. Tanaka Continuous smoking and progression of arterial stiffening: a prospective study J Am Coll Cardiol 55 2010 1979 1987
17. H.M. Johnson, L.K. Gossett, and M.E. Piper Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial J Am Coll Cardiol 55 2010 1988 1995
18. F. Akdim, E.S.G. Stroes, and E.J.G. Sijbrands Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy J Am Coll Cardiol 55 2010 1611 1618
19. K. Grnsbo, O. Melander, and L. Wallentin Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment J Am Coll Cardiol 55 2010 1362 1369
20. D. Sibbing, J. Stegherr, and S. Braun A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment J Am Coll Cardiol 55 2010 558 565
21. E.I. Lev, A. Solodky, and N. Harel Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation J Am Coll Cardiol 55 2010 114 121
22. G. Gajos, P. Rostoff, A. Undas, and W. Piwowarska Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 Fatty Acids After PCI to Modify Responsiveness to Dual Antiplatelet Therapy) study J Am Coll Cardiol 55 2010 1671 1678
23. D.J. Angiolillo, J.F. Saucedo, R. DeRaad SWAP Investigators Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (Switching Antiplatelet) study J Am Coll Cardiol 56 2010 1017 1023
24. J.K. Shim, Y.L. Kwak, J.C. Kim, Y.S. Choi, K.J. Yoo, and Y. Song Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement following off-pump coronary bypass surgery J Am Coll Cardiol 56 2010 1994 2002
25. G. Gao, Z. Zheng, Y. Pi, B. Lu, J. Lu, and S. Hu Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery: a single randomized, controlled trial J Am Coll Cardiol 56 2010 1639 1643
26. J. Afilalo, M.J. Eisenberg, and J.F. Morin Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery J Am Coll Cardiol 56 2010 1668 1676
27. M.R.P. Markus, J. Stritzke, U. Siewert MONICA/KORA Investigators Variation in body composition determines long-term blood pressure changes in pre-hypertension: the MONICA/KORA (Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Research in the Region of Augsburg) cohort study J Am Coll Cardiol 56 2010 65 76
28. I.J.M. Scheffers, A.A. Kroon, and J. Schmidli Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study J Am Coll Cardiol 56 2010 1254 1258
29. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis J Am Coll Cardiol 55 2010 1318 1327
30. A. Benetos, F. Thomas, and L. Joly Pulse pressure amplification: a mechanical biomarker of cardiovascular risk J Am Coll Cardiol 55 2010 1032 1037
31. C. Meyer, C. Heiss, and C. Drexhage Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function J Am Coll Cardiol 55 2010 454 459
32. M.J. Jardine, T. Ninomiya, and V. Perkovic Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial J Am Coll Cardiol 56 2010 956 965
33. D.J. Angiolillo, E. Bernardo, and D. Capodanno Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy J Am Coll Cardiol 55 2010 1139 1146
34. P. Damman, A. Hirsch, and F. Windhausen 5-Year clinical outcomes in the ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial: a randomized comparison of an early invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome J Am Coll Cardiol 55 2010 858 864
35. J.A. Bittl, and D.J. Maron Having it both ways J Am Coll Cardiol 55 2010 865 866
36. K.A.A. Fox, T.C. Clayton, and P. Damman Long-term outcome of a routine versus selective invasive strategy in patients with non ST-segment elevation acute coronary syndrome: a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
37. M.C.A. Kramer, S.Z.H. Rittersma, and R.J. de Winter Relationship of thrombus to underlying plaque morphology in sudden coronary death J Am Coll Cardiol 55 2010 122 132
38. R.I. Levin Plaque vulnerability pathologic form and patient fate J Am Coll Cardiol 55 2010 133 134
39. A. Migliorini, A. Stabile, and A.E. Rodriguez Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction: the JETSTENT trial J Am Coll Cardiol 56 2010 1298 1306
40. A. Kastrati, R.A. Byrne, and A. Schomig Is it time to jettison complex mechanical thrombectomy in favor of simple manual aspiration devices? J Am Coll Cardiol 56 2010 1307 1309
41. D.W. Park, Y.H. Kim, and S.C. Yun Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent With Sirolimus-Eluting and Paclitaxel-Eluting Stent for Coronary Lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
42. U. Zeymer, A. Margenet, and M. Haude Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI trial J Am Coll Cardiol 56 2010 463 469
43. A. Akerblom, S.K. James, and M. Koutouzis Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) J Am Coll Cardiol 56 2010 470 475
44. J. Mehilli, R.A. Byrne, and K. Tiroch Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
45. M.B. Leon, L. Mauri, and J.J. Popma A randomized comparison of the Endeavor zotarolimus-eluting stent versus the Taxus paclitaxel-eluting stent in de novo native coronary lesions: 12-month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
46. H. Thiele, L. Hildebrand, and C. Schirdewahn Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate Percutaneous Coronary Intervention Acute Myocardial Infarction N-ACC) trial J Am Coll Cardiol 55 2010 2201 2209
47. E. Bohmer, P. Hoffmann, M. Abdelnoor, H. Arnesen, and S. Halvorsen Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances: results of the NORDISTEMI (Norwegian study on District Treatment of ST-Elevation Myocardial Infarction) J Am Coll Cardiol 55 2010 102 110
48. G. Di Sciascio, G. Patti, and V. Pasceri Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) randomized trial J Am Coll Cardiol 56 2010 550 557
49. P.A.L. Tonino, W.F. Fearon, and B. De Bruyne Angiographic versus functional severity of coronary artery stenoses in the FAME study: Fractional Flow Reserve Versus Angiography for Multivessel Evaluation J Am Coll Cardiol 55 2010 2816 2821
50. N.H.J. Pijls, W.F. Fearon, and P.A.L. Tonino Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study J Am Coll Cardiol 56 2010 177 184
51. A. Kaltoft, H. Kelbaek, and L. Klovgaard Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial J Am Coll Cardiol 55 2010 867 871
52. R. Violini, C. Musto, and F. De Felice Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: 3-year results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction) trial J Am Coll Cardiol 55 2010 810 814
53. P. Sorajja, B.J. Gersh, and D.A. Cox Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 55 2010 1416 1424
54. A.P. Banning, S. Westaby, and M.C. Morice Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 2010 1067 1075
55. H.L. Dauerman Percutaneous coronary intervention, diabetes mellitus, and death J Am Coll Cardiol 55 2010 1076 1079
56. G.W. Stone, H. Parise, and B.W. Witzenbichler Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 56 2010 1597 1604
57. R.A. Byrne, A. Kastrati, and K. Tiroch 2-Year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based cypher and endeavor, drug-eluting stents J Am Coll Cardiol 55 2010 2536 2543
58. D.W. Park, K.B. Seung, and Y.H. Kim Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry J Am Coll Cardiol 56 2010 117 124
59. D.W. Park, Y.H. Kim, and S.C. Yun Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left Main Revascularization) registry J Am Coll Cardiol 56 2010 1366 1375
60. P.W. Serruys, Y. Onuma, and S. Garg 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
61. Y.B. Song, J.Y. Hahn, and S.H. Choi Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations: results from the COBIS (Coronary Bifurcation Stenting) registry J Am Coll Cardiol 55 2010 1743 1750
62. G. Nakazawa, S.K. Yazdani, A.V. Finn, M. Vorpahl, F.D. Kolodgie, and R. Virmani Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation J Am Coll Cardiol 55 2010 1679 1687
63. G. Ndrepepa, K. Tiroch, and M. Fusaro 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction J Am Coll Cardiol 55 2010 2383 2389
64. W. Hochholzer, D. Trenk, and M.F. Fromm Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement J Am Coll Cardiol 55 2010 2427 2434
65. E. Stabile, L. Salemme, and G. Sorropago Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients J Am Coll Cardiol 55 2010 1661 1667
66. A.J. Feiring, M. Krahn, L. Nelson, A. Wesolowski, D. Eastwood, and A. Szabo Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PARADISE (Preventing Amputations Using Drug Eluting Stents) trial J Am Coll Cardiol 55 2010 1580 1589
67. M. Takano, M. Yamamoto, and S. Inami Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents: extended late-phase observation by intracoronary optical coherence tomography J Am Coll Cardiol 55 2010 26 32
68. T. Kubo, A. Maehara, and G.S. Mintz The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization J Am Coll Cardiol 55 2010 1590 1597
69. O. Bayturan, S. Kapadia, and S.J. Nicholls Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol J Am Coll Cardiol 55 2010 2736 2742
70. S.J. Nicholls, A. Hsu, and K. Wolski Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407
71. S. Tsimikas, Z. Mallat, and P.J. Talmud Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events J Am Coll Cardiol 56 2010 946 955
72. S. Erqou, A. Thompson, and E. Di Angelantonio Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants J Am Coll Cardiol 55 2010 2160 2167
73. S. Agarwal, E.M. Tuzcu, and M.Y. Desai Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy J Am Coll Cardiol 55 2010 823 834
74. C. De Vos, R. Pisters, and R. Nieuwlatt Progression from paroxysmal to persistent atrial fibrillation J Am Coll Cardiol 55 2010 726 731
75. A. Jahangir, and S. Murarka Progression of paroxysmal to persistent atrial fibrillation factors promoting the HATCH score J Am Coll Cardiol 55 2010 732 734
76. D. Darbar Genetics of atrial fibrillation: rare mutations, common polymorphisms, and clinical relevance Heart Rhythm 5 2008 483 486
77. J. Hall, A. Barac, and E.J. Benjamin Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation? J Am Coll Cardiol 55 2010 754 757
78. D. Husser, V. Adams, C. Piorkowski, G. Hindricks, and A. Bollmann Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation J Am Coll Cardiol 55 2010 747 753
79. K. Nishida, J.-F. Sarrazin, and A. Fujikim Roles of the left atrial roof and pulmonary veins in the anatomic substrate for persistent atrial fibrillation and ablation in a canine model J Am Coll Cardiol 56 2010 1728 1736
80. A. Burashnikov, S. Sicouri, J.M. Di Diego, L. Belardinelli, and C. Antzelevitch Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation J Am Coll Cardiol 56 2010 1216 1224
81. V.V. Fedorov, A.V. Glukhov, and R. Chang Optical mapping of the isolated coronary-perfused human sinus node J Am Coll Cardiol 56 2010 1386 1394
82. M.J. Reed, D.E. Newby, A.J. Coull, R.J. Prescott, K.G. Jacques, and A.J. Gray The ROSE (Risk Stratification of Syncope in the Emergency Department) study J Am Coll Cardiol 55 2010 713 721
83. M. Weisfeldt, C.M. Sitlani, and J.P. Ornato Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million J Am Coll Cardiol 55 2010 1713 1720
84. E.M. Kanoupakis, E.G. Manios, and E.M. Kallergis Serum markers of collagen turnover predict future shocks in implantable cardioverter- defibrillator recipients with dilated cardiomyopathy on optimal treatment J Am Coll Cardiol 55 2010 2753 2759
85. D.S. Lee, A.D. Krahn, and J.S. Healey Evaluation of early complications related to de novo cardioverter defibrillator implantation: insights from the Ontario ICD database J Am Coll Cardiol 55 2010 774 782
86. M.K. Chung, S.J. Szymkiewicz, and M. Shao Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival J Am Coll Cardiol 56 2010 194 203
87. R.J. Verdino The wearable cardioverter-defibrillator: life-saving attire or "fashion faux pas"? J Am Coll Cardiol 56 2010 204 205
88. S. Nakahara, R. Tung, and R.J. Ramirez Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia J Am Coll Cardiol 55 2010 2355 2365
89. F. Sacher, K. Roberts-Thomson, and P. Maury Epicardial ventricular tachycardia ablation a multicenter safety study J Am Coll Cardiol 55 2010 2366 2372
90. H.H. Hsia Epicardial ventricular tachycardia ablation an evolution of needs J Am Coll Cardiol 55 2010 2373 2375
91. S. Viskin, P.G. Postema, and Z.A. Bhuiyan The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome J Am Coll Cardiol 55 2010 1955 1961
92. C. Jons, A.J. Moss, and I. Goldenberg Risk of fatal arrhythmic events in long QT syndrome patients after syncope J Am Coll Cardiol 55 2010 783 788
93. N. Derval, P. Steendijk, and A. Deplagne Optimizing hemodynamics in heart failure patients by systematic screening of LV pacing sites: the lateral LV wall and the coronary sinus are rarely the best sites J Am Coll Cardiol 55 2010 566 575
94. D.D. Spragg, J. Dong, and B.J. Fetics Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy J Am Coll Cardiol 56 2010 774 781
95. N. Derval, and P. Jais Optimizing hemodynamics in cardiac resynchronization therapy by left ventricular pacing site: you find only what you are looking for J Am Coll Cardiol 56 2010 782 783
96. K. Yoshida, T.Y. Liu, and C. Scott The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia J Am Coll Cardiol 56 2010 969 979
97. J. Almendral, and F. Marchlinski Is it the same or a different ventricular tachycardia? An additional use for defibrillator electrograms J Am Coll Cardiol 56 2010 980 982
98. D. Singh, E. Cingolani, G.A. Diamond, and S. Kaul Dronedarone for atrial fibrillation: have we expanded the antiarrhythmic armamentarium? J Am Coll Cardiol 55 2010 1569 1576
99. A.S. Fein, Y. Wang, J.P. Curtis, F.A. Masoudi, P.D. Varosy, M.R. Reynolds National Cardiovascular Data Registry Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator registry J Am Coll Cardiol 56 2010 766 773
100. B. John, M.K. Stiles, and P. Kuklik Reverse remodeling of the atria after treatment of chronic stretch in humans J Am Coll Cardiol 55 2010 1217 1226
101. U.B. Tedrow, D. Conen, and P.M. Ridker The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation The WHS (Women's Health Study) J Am Coll Cardiol 55 2010 2319 2327
102. E. Jaeggi, C. Laskin, R. Hamilton, J. Kingdom, and E. Silverman The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants J Am Coll Cardiol 55 2010 2778 2784
103. H.J. Avis, B.A. Hutten, and C. Gagn Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 2010 1121 1126
104. P.F. Kantor, J.R. Abraham, A.I. Dipchand, L.N. Benson, and A.N. Redington The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy J Am Coll Cardiol 55 2010 1377 1384
105. M. Moulik, J.P. Breinholt, and W.J. Dreyer Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients J Am Coll Cardiol 56 2010 582 592
106. C. Apitz, J.T. Reyes, H. Holtby, T. Humpl, and A.N. Redington Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension J Am Coll Cardiol 55 2010 1456 1462
107. D.M. Harrild, A.J. Powell, and T.X. Tran Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis: risk factors and relationship to exercise capacity and ventricular volume and function J Am Coll Cardiol 55 2010 1041 1047
108. L.A. Latson Balloon pulmonary valvuloplasty, pulmonary regurgitation, and exercise capacity: the good, the bad, and the not yet clear J Am Coll Cardiol 55 2010 1048 1049
109. R.H. Rathod, A. Prakash, A.J. Powell, and T. Geva Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation J Am Coll Cardiol 55 2010 1721 1728
110. E.A. Stephenson, M. Lu, C.I. Berul Pediatric Heart Network Investigators Arrhythmias in a contemporary Fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study J Am Coll Cardiol 56 2010 890 896
111. G.F. Van Hare On the evolution of the Fontan operation: from an electrophysiologist's perspective J Am Coll Cardiol 56 2010 897 898
112. A.M. Valente, A.B. Bhatt, S. Cook AARCC (Alliance for Adult Research in Congenital Cardiology) Investigators The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study J Am Coll Cardiol 56 2010 144 150
113. A. Marelli Four decades of the Fontan operation: did we ever have a leg to stand on? J Am Coll Cardiol 56 2010 151 153
114. D. Tobler, W.G. Williams, and A. Jegatheeswaran Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries J Am Coll Cardiol 56 2010 58 64
115. S.C. Siu, and C.K. Silversides Bicuspid aortic valve disease J Am Coll Cardiol 55 2010 2789 2800
116. P. Khairy, R. Ionescu-Ittu, A.S. Mackie, M. Abrahamowicz, L. Pilote, and A.J. Marelli Changing mortality in congenital heart disease J Am Coll Cardiol 56 2010 1149 1157
117. J.G. Rogers, K.D. Aaronson, A.J. Boyle HeartMate II Investigators Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
118. R.C. Starling Improved quantity and quality of life: a winning combination to treat advanced heart failure J Am Coll Cardiol 55 2010 1835 1836
119. N. Uriel, S.W. Pak, and U.P. Jorde Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
120. L.W. Miller The development of the von Willebrand syndrome with the use of continuous flow left ventricular assist devices: a cause-and-effect relationship J Am Coll Cardiol 56 2010 1214 1215
121. B.A. Borlaug, T.P. Olson, and C.S. Lam Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction J Am Coll Cardiol 56 2010 845 854
122. W.J. Paulus Culprit mechanism(s) for exercise intolerance in heart failure with normal ejection fraction J Am Coll Cardiol 56 2010 864 866
123. M.T. Maeder, B.R. Thompson, H.P. Brunner-La Rocca, and D.M. Kaye Cardiac and vascular responses are coupled, and abnormalities in several components may interact to promote exertional intolerance in HFpEF J Am Coll Cardiol 56 2010 855 863
124. M. Penicka, J. Bartunek, and H. Trakalova Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis J Am Coll Cardiol 55 2010 1701 1710
125. C.S. Lam Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion? J Am Coll Cardiol 55 2010 1711 1712
126. A.M. From, C.G. Scott, and H.H. Chen The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study J Am Coll Cardiol 55 2010 300 305
127. B. Greenberg Pre-clinical diastolic dysfunction in diabetic patients: where do we go from here? J Am Coll Cardiol 55 2010 306 308
128. M.A. Weber, G.L. Bakris, and K. Jamerson Cardiovascular events during differing hypertension therapies in patients with diabetes J Am Coll Cardiol 56 2010 77 85
129. A. Jabbour, P.S. Macdonald, and A.M. Keogh Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial J Am Coll Cardiol 55 2010 1780 1787
130. D. Cardinale, A. Colombo, and G. Lamantia Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
131. A. Sezai, M. Hata, and T. Niino Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University Working Group Study of Low-Dose Human ANP Infusion Therapy During Cardiac Surgery) for left ventricular dysfunction J Am Coll Cardiol 55 2010 1844 1851
132. A.A. Voors, and D.J. van Veldhuisen Cardiorenal effects of recombinant human natriuretic peptides J Am Coll Cardiol 55 2010 1852 1853
133. D. Verhaert, R. Grimm, and C. Puntawangkoon Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up J Am Coll Cardiol 55 2010 1788 1795
134. N. Derval, and P. Jais Optimizing hemodynamics in cardiac resynchronization therapy by LV pacing site: you find only what you are looking for J Am Coll Cardiol 56 2010 782 783
135. S.I. Chaudhry, Y. Wang, T.M. Gill, and H.M. Krumholz Geriatric conditions and subsequent mortality in older patients with heart failure J Am Coll Cardiol 55 2010 309 316
136. B.R. Shah, P.A. Cowper, and S.M. O'Brien Patterns of cardiac stress testing after revascularization in community practice J Am Coll Cardiol 56 2010 1328 1334
137. I. Janszky, S. Ahnve, I. Lundberg, and T. Hemmingsson Early-onset depression, anxiety, and risk of subsequent coronary heart disease J Am Coll Cardiol 56 2010 31 37
138. A.M. Roest, E.J. Martens, P. de Jonge, and J. Denollet Anxiety and risk of incident coronary heart disease A meta-analysis J Am Coll Cardiol 56 2010 38 46
139. K.J. Mukamal, C.M. Chen, S.R. Rao, and R.A. Breslow Alcohol consumption and cardiovascular mortality among U.S. adults, 19872002 J Am Coll Cardiol 56 2010 1328 1335
140. V. Aboyans, I. Desormais, P. Lacroix, J. Salazar, M.H. Criqui, and M. Laskar The general prognosis of patients with peripheral arterial disease differs according to the disease localization J Am Coll Cardiol 55 2010 898 903
141. J.V. Freeman, Y. Wang, J.P. Curtis, P.A. Heidenreich, and M.A. Hlatky The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the ICD registry J Am Coll Cardiol 56 2010 1133 1139
142. I. Gottlieb, J.M. Miller, and A. Arbab-Zadeh The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography J Am Coll Cardiol 55 2010 627 634
143. P.S. Chan, W.J. Oetgen, and D. Buchanan Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation and Clinical Excellence) program J Am Coll Cardiol 56 2010 8 14
144. S.V. Rao Scaling new heights in quality improvement: the PINNACLE (Practice Innovation and Clinical Excellent) program J Am Coll Cardiol 56 2010 15 17
145. E.D. Peterson, D. Dai, and E.R. DeLong Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry J Am Coll Cardiol 55 2010 1923 1932
146. D.J. Kereiakes Cultivating prognosis following percutaneous coronary intervention: the American College of Cardiology/National Cardiovascular Data Registry Risk Score J Am Coll Cardiol 55 2010 1933 1935
147. A. Pelliccia, N. Kinoshita, and C. Pisicchio Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes J Am Coll Cardiol 55 2010 1619 1625
148. P.S. Bhella, and B.D. Levine The heart of a champion J Am Coll Cardiol 55 2010 1626 1628
149. N. Hofman, H.L. Tan, M. Alders, I.M. van Langen, and A.A. Wilde Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 55 2010 2570 2576
150. C. Schwartz, E. Gerard, K. Perronnet, and J.L. Morel Measurement of in situ phytoextraction of zinc by spontaneous metallophytes growing on a former smelter site Sci Total Environ 279 2001 215 221
151. S.G. Priori, P.J. Schwartz, and C. Napolitano Risk stratification in the long-QT syndrome N Engl J Med 348 2003 1866 1874
152. H.L. Tan, A. Bardai, and W. Shimizu Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications Circulation 114 2006 2096 2103
153. P.J. Schwartz Cascades or waterfalls, the cataracts of genetic screening are being opened on clinical cardiology J Am Coll Cardiol 55 2010 2577 2579
154. M. Tomas, C. Napolitano, and L. De Giuli Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome J Am Coll Cardiol 55 2010 2745 2752
155. M. Benn, B.G. Nordestgaard, P. Grande, P. Schnohr, and A. Tybjaerg-Hansen PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses J Am Coll Cardiol 55 2010 2833 2842
156. C. Newton-Cheh, and J.G. Smith What can human genetics teach us about the causes of cardiovascular disease? J Am Coll Cardiol 55 2010 2843 2845
157. T.M. Teslovich, K. Musunuru, and A.V. Smith Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
158. J.S. Hulot, J.P. Collet, and J. Silvain Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19 (*)2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis J Am Coll Cardiol 56 2010 134 143
159. S. Dandona, A.F. Stewart, and L. Chen Gene dosage of the common variant 9p21 predicts severity of coronary artery disease J Am Coll Cardiol 56 2010 479 486
160. J.L. Anderson, and B.D. Horne The 9p21 locus and coronary heart disease: initiator, promoter, or precipitator? J Am Coll Cardiol 56 2010 487 489
161. A.E. Baird Genetics and genomics of stroke: novel approaches J Am Coll Cardiol 56 2010 245 253
162. P. Jousilahti, D. Rastenyte, J. Tuomilehto, C. Sarti, and E. Vartiainen Parental history of cardiovascular disease and risk of stroke A prospective follow-up of 14371 middle-aged men and women in Finland Stroke 28 1997 1361 1366
163. N.K. Lakdawala, L. Dellefave, and C.S. Redwood Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy J Am Coll Cardiol 55 2010 320 329
164. J.C. Tardiff Tropomyosin and dilated cardiomyopathy: revenge of the actinomyosin "gatekeeper." J Am Coll Cardiol 55 2010 330 332
165. C. Chiu, R.D. Bagnall, and J. Ingles Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis J Am Coll Cardiol 55 2010 1127 1135
166. J.M. Bos, and M.J. Ackerman Z-disc genes in hypertrophic cardiomyopathy: stretching the cardiomyopathies? J Am Coll Cardiol 55 2010 1136 1138
167. F. Girolami, C.Y. Ho, and C. Semsarian Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations J Am Coll Cardiol 55 2010 1444 1453
168. R.E. Hershberger A glimpse into multigene rare variant genetics: triple mutations in hypertrophic cardiomyopathy J Am Coll Cardiol 55 2010 1454 1455
169. T. Xu, Z. Yang, and M. Vatta Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy J Am Coll Cardiol 55 2010 587 597
170. R.S. Epstein, T.P. Moyer, and R.E. Aubert Varfarin genotyping reduces hospitalization rates: results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study) J Am Coll Cardiol 55 2010 2804 2812
171. G.S. Ginsburg, and D. Voora The long and winding road to warfarin pharmacogenetic testing J Am Coll Cardiol 55 2010 2813 2815
172. K. Zhang, F. Rao, and L. Wang Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension J Am Coll Cardiol 55 2010 1463 1475
173. P. Panizzi, F.K. Swirski, and J.L. Figueiredo Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis J Am Coll Cardiol 55 2010 16293
174. L. Cardilo-Reis, J.L. Witztum, and C.J. Binder When monocytes come (too) close to our hearts J Am Coll Cardiol 55 2010 1639 1641
175. C. Dubois, X. Liu, and P. Claus Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction J Am Coll Cardiol 55 2010 2232 2243
176. S.W. Kim, H. Kim, H.J. Cho, J.U. Lee, R. Levit, and Y.S. Yoon Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease J Am Coll Cardiol 56 2010 593 607
177. R.D. Simari, and R. Gulati Peripheral blood CD31+ cells for the treatment of ischemic vascular disease J Am Coll Cardiol 56 2010 608 609
178. A. Ogino, G. Takemura, and M. Kawasaki Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia J Am Coll Cardiol 56 2010 1949 1958
179. P. van der Meer, E. Lipsic, and D.J. Van Veldhuisen Asialo-erythropoietin to protect the failing heart: is it possible to run with the hare and hunt with the hounds? J Am Coll Cardiol 56 2010 1959 1960
180. M. Rajesh, P. Mukhopadhyay, and S. Batkai Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy J Am Coll Cardiol 56 2010 2115 2125
181. H. Zheng, M. Tang, and Q. Zheng Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy J Am Coll Cardiol 56 2010 1418 1426
182. F. Villarreal, and W.Y.W. Lew Protein quality control in heart disease: using established drugs to target novel mechanisms J Am Coll Cardiol 56 2010 1427 1429
183. K. Zhang, F. Rao, and L. Wang Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension J Am Coll cardiol 55 2010 1463 1475
184. M. Halle, A. Gabrielsen, and G. Paulsson-Berne Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries J Am Coll Cardiol 55 2010 1227 1236
185. N.L. Weintraub, W.K. Jones, and D. Manka Understanding radiation-induced vascular disease J Am Coll Cardiol 55 2010 1237 1239
186. J. Suzuki, M. Ogawa, and K. Takayama Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice J Am Coll Cardiol 55 2010 904 913
187. C. Kupatt Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy J Am Coll Cardiol 55 2010 914 916
188. H. Gonzalez-Navarro, Y.N. Abu Nabah, and A. Vinue p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis J Am Coll Cardiol 55 2010 2258 2268
189. R. Wessely Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors J Am Coll Cardiol 55 2010 2269 2271
190. O. Adam, D. Lavall, and K. Theobald Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation J Am Coll Cardiol 55 2010 469 480
191. J.K. Liao Rac1 and connective tissue growth factor The missing link between atrial remodeling and the pathogenesis of atrial fibrillation? J Am Coll Cardiol 55 2010 481 482
192. A. Tomaschitz, W. Maerz, and S. Pilz Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range J Am Coll Cardiol 55 2010 2171 2180
193. E.L. Bravo, and M.A. Rafey New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressure J Am Coll Cardiol 55 2010 2181 2182
194. C. Dellas, M. Puls, and M. Lankeit Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism J Am Coll Cardiol 55 2010 2158 2159
195. S.Z. Goldhaber Fine-tuning risk stratification for acute pulmonary embolism with cardiac biomarkers J Am Coll Cardiol 55 2010 2150 2157
196. P.M. McKie, A. Cataliotti, and B.D. Lahr The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects J Am Coll Cardiol 55 2010 2148 2149
197. J.E. Ho, and D. Levy B-Type natriuretic peptide testing in the general population: are we ready for prime time? J Am Coll Cardiol 55 2010 2140 2147
198. A. Kalogeropoulos, V. Georgiopoulou, and B.M. Psaty Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study J Am Coll Cardiol 55 2010 2138 2139
199. J.N. Cohn Detecting the patient at risk of heart failure J Am Coll Cardiol 55 2010 2129 2137
200. M. Bonaca, B. Scirica, and M. Sabatine Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol 55 2010 2125 2128
201. R.L. Jesse On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction J Am Coll Cardiol 55 2010 2118 2124
202. H.C. Kim, P. Greenland, and J.E. Rossouw Multimarker prediction of coronary heart disease risk: the Women's Health Initiative J Am Coll Cardiol 55 2010 2092 2095
203. T.J. Wang Multiple biomarkers for predicting cardiovascular events, lessons learned J Am Coll Cardiol 55 2010 2092 2095
204. D.A. Morrow, B.M. Scirica, and M.S. Sabatine B-type natriuretic peptide and the effect of ranolazine in patients with non-ST segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute CoronaryThrombolysis In Myocardial Infaction 36) trial J Am Coll Cardiol 55 2010 1189 1196
205. R.M. Califf, S.H. Shah, and L.K. Newby Biomarker bonanza? J Am Coll Cardiol 55 2010 1197 1199
206. C.R. de Filippi, R.H. Christenson, J.S. Gottdiener, W.J. Kop, and S.L. Seliger Dynamic cardiovascular risk assessment in elderly people The role of repeated N-terminal pro-B-type natriuretic peptide testing J Am Coll Cardiol 55 2010 441 450
207. R.A. Weir, A.M. Miller, and G.E. Murpjy Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction J Am Coll Cardiol 55 2010 243 250
208. S.A. Moore, and J.L. Januzzi Jr Found in translation: soluble ST2 and heart disease J Am Coll Cardiol 55 2010 243 250
209. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-Terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP Assisted Treatment to Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2010 53 60
210. A. Maisel Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? J Am Coll Cardiol 55 2010 61 64
211. R. Erbel, S. Mohlenkamp, and S. Moebus Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis The Heinz Nixdorf Recall Study J Am Coll Cardiol 56 2010 1397 1406
212. J.K. Min, F.Y. Lin, and D.S. Gidseg Determinants of coronary calcium conversion among patients with a normal coronary calcium scan What is the "warranty period" for remaining normal? J Am Coll Cardiol 55 2010 1110 1117
213. H.S. Hecht A zero coronary artery calcium score Priceless J Am Coll Cardiol 55 2010 1118 1120
214. J.W. McEvoy, M.J. Blaha, and A.P. DeFilippis Coronary artery calcium progression: an important clinical measurement? A review of published reports J Am Coll Cardiol 56 2010 1613 1622
215. A.J. Einstein, L.L. Johnson, and S. Bokhari Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET/CT and SPECT/CT with standard Agatston score J Am Coll Cardiol 56 2010 1914 1921
216. T. Sharir, P.J. Slomka, and S.W. Hayes Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and function J Am Coll Cardiol 55 2010 1965 1974
217. F.J.T. Wackers Cardiac single-photon emission computed tomography myocardial perfusion imaging Finally up to speed? J Am Coll Cardiol 55 2010 1975 1978
218. C.J. Pepine, R.D. Anderson, and B.L. Sharaf Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia J Am Coll Cardiol 55 2010 2825 2832
219. M.C. Kontos, V. Dilsizian, and F. Weiland Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes J Am Coll Cardiol 56 2010 290 299
220. F. Pugliese, O. Gaemperli, and A.R. Kinderlerer Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography J Am Coll Cardiol 56 2010 653 661
221. C.L. Hung, A. Verma, and H. Uno Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction J Am Coll Cardiol 56 2010 1812 1822
222. L.A. Pierard, and P. Lancellotti Risk stratification after myocardial infarction: toward novel quantitative assessment of left ventricular mechanics? J Am Coll Cardiol 56 2010 1823 1825
223. J.P. Piccini, A.Z. Starr, and J.R. Horton Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary artery disease and left ventricular ejection fraction >35% J Am Coll Cardiol 56 2010 206 214
224. R.J. Myerburg, and R.C. Hendel Expanding risk-profiling strategies for prediction and prevention of sudden cardiac death J Am Coll Cardiol 56 2010 215 217
225. S.M. Chang, F. Nabi, J. Xu, U. Raza, and J.J. Mahmarian Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient morality with reduced radiation exposure J Am Coll Cardiol 55 2010 221 230
226. A.E. Iskandrian Stress-only myocardial perfusion imaging: a new paradigm J Am Coll Cardiol 55 2010 231 233
227. R.C. Hendel, M. Cerqueira, and P.S. Douglas A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria J Am Coll Cardiol 55 2010 156 162
228. B.J.W. Chow, G.A. Wells, and L. Chen Prognostic value of 64-Slice cardiac computed tomography: severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction J Am Coll Cardiol 55 2010 1017 1028
229. D.B. Mark, and D.F. Kong Cardiac computed tomographic angiography: what's the prognosis? J Am Coll Cardiol 55 2010 1029 1031
230. S.V. Raman, O.P. Simonetti, and M.W. Winner III Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST segment elevation acute coronary syndrome J Am Coll Cardiol 55 2010 2480 2488
231. I. Eitel, S. Desch, and G. Fuernau Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction J Am Coll Cardiol 55 2010 2470 2479
232. E. Larose, J. Rodes-Cabau, and P. Pibarot Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance J Am Coll Cardiol 55 2010 2459 2469
233. F.J. Klocke Cardiac magnetic resonance measurements of area at risk and infarct size in ischemic syndromes J Am Coll Cardiol 55 2010 2489 2490
234. H. Kim, A. Farzaneh-Far, and R.J. Kim Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications J Am Coll Cardiol 55 2010 1 16
235. S.C. Bekkers, S.K. Yazdani, R. Virmani, and J. Waltenberger Microvascular obstruction: underlying pathophysiology and clinical diagnosis J Am Coll Cardiol 55 2010 1649 1660
236. N. Mewton, P. Croisille, and G. Gahide Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction J Am Coll Cardiol 55 2010 1200 1205
237. S. Heidary, H. Patel, and J. Chung Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events J Am Coll Cardiol 55 2010 2762 2768
238. G.D. Aquaro, A. Pingitore, E. Strata, G. Di Bella, S. Molinaro, and M. Lombardi Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology J Am Coll Cardiol 56 2010 1235 1243
239. G. Korosoglou, Y. Elhmidi, and H. Steen Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion J Am Coll Cardiol 56 2010 1225 1234
240. W.G. Hundley The use of cardiovascular magnetic resonance to identify adverse cardiac prognosis: an important step in reducing image-related health care expenditures J Am Coll Cardiol 56 2010 1244 1246
241. A.R. Patel, P.F. Antkowiak, and K.R. Nandalur Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis J Am Coll Cardiol 56 2010 561 569
242. M. Neizel, G. Korosoglou, and D. Lossnitzer Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up J Am Coll Cardiol 56 2010 1056 1062
243. M.C. Langham, T.F. Floyd, E.R. Mohler, J.F. Magland, and F.W. Wehrli Evaluation of cuff-induced ischemia in the lower extremity by magnetic resonance oximetry J Am Coll Cardiol 55 2010 598 606
244. E. Nagel Magnetic resonance coronary angiography: the condemned live longer J Am Coll Cardiol 56 2010 992 994
245. S. Kato, K. Kitagawa, and N. Ishida Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial J Am Coll Cardiol 56 2010 983 991
246. I. Gottlieb, J.M. Miller, and A. Arbab-Zadeh The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography J Am Coll Cardiol 55 2010 627 634
247. B.J. Chow, G.A. Wells, and L. Chen Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis and left ventricular ejection fraction J Am Coll Cardiol 55 2010 1017 1028
248. Hoffman U, Bamberg F, Chae CU, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction Using Computer Assisted Tomography) trial. J Am Coll Cardiol 53:164250.
249. L.J. Rijzewijk, J.T. Jonker, and R.W. van der Meer Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes J Am Coll Cardiol 56 2010 225 233
250. J. Rodes-Cabau, J.H. Webb, A. Cheung, and J. Ye Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
251. B. Iung, D. Himbert, and A. Vahanian A step forward in the evaluation of transcatheter aortic valve implantation J Am Coll Cardiol 55 2010 1091 1092
252. M. Pasic, A. Unbehaun, and S. Dreysse Transapical aortic valve implantation in 175 consecutive patients: excellent outcome in very high-risk patients J Am Coll Cardiol 56 2010 813 820
253. M.Z. Khawaja, P. Haworth, and Z. Ghuran Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprosthesis: CoreValve for failed bioprosthetic aortic valve replacements J Am Coll Cardiol 55 2010 97 101
254. A. Page, J.G. Dumesnil, and M.A. Clavel Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin) J Am Coll Cardiol 55 2010 1867 1874
255. T. Le Tourneau, D. Messika-Zeitoun, and A. Russo Impact of left atrial volume on clinical outcome in organic mitral regurgitation J Am Coll Cardiol 56 2010 570 578
256. R.A. Levine, and S. Nattel Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation J Am Coll Cardiol 56 2010 579 581
257. J. Magne, P. Lancellotti, and L.A. Pierard Exercise-induced changes in degenerative mitral regurgitation J Am Coll Cardiol 56 2010 300 309
258. F. Flachskampf Mitral regurgitation is incompletely characterized at rest J Am Coll Cardiol 56 2010 310 313
259. D. Schmidt, P.E. Dijkman, and A. Driessen-Mol Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells J Am Coll Cardiol 56 2010 510 520
260. R.S. Rosenson, H. Hislop, M. Elliott, Y. Stasiv, M. Goulder, and D. Waters Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients J Am Coll Cardiol 56 2010 1079 1088
261. R. Waksman, R. Torguson, and K.M. Kent A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome J Am Coll Cardiol 55 2010 2727 2735
262. T.C. Villines, E.J. Stanek, P.J. Devine, M. Turco, and M. Miller The ARBITER-HALTS trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose and treatment duration J Am Coll Cardiol 55 2010 2721 2726
263. D. Steinberg Earlier intervention in the management of hypercholesterolemia: what are we waiting for? J Am Coll Cardiol 56 2010 627 629
264. J.S. Forrester Redefining normal low-density lipoprotein cholesterol: a strategy to unseat coronary disease as the nation's leading killer J Am Coll Cardiol 56 2010 630 636
265. M.J. Fletcher, and S.B. Hulley Statin therapy in young adults: ready for prime time? J Am Coll Cardiol 56 2010 637 640